Search research articles
Contact Us
Filters
Showing results (1-10 of 495) with videos related to
Page
of 50
Sort By:
European Neurology
|
October 4, 2014
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways
Diego Centonze
JAMA Neurology
|
February 10, 2015
Treatment decisions for patients with active multiple sclerosis
Olaf Stüve, Diego Centonze
Nature Metabolism
|
May 21, 2026
Irisin as a driver of neuroprotection in multiple sclerosis
Diego Centonze, Alessandra Musella
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 14, 2025
Diagnostic uncertainty in the era of biosimilar natalizumab-The case for harmonizing anti-JCV antibody testing
Tjalf Ziemssen, Diego Centonze
Sleep Science (Sao Paulo, Brazil)
|
December 28, 2019
Oral L-carnitine and pregnancy: real opportunity for narcoleptic women?
Andrea Romigi, Diego Centonze
Neurology and Therapy
|
October 31, 2021
Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
Carlo Avolio, Diego Centonze
Methods in Molecular Biology (Clifton, N.J.)
|
September 24, 2022
Electrophysiology of Endocannabinoid Signaling
Alessandra Musella, Diego Centonze
CNS Neuroscience & Therapeutics
|
December 6, 2014
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes
Vincenzo Di Marzo, Diego Centonze
Brain : a Journal of Neurology
|
July 20, 2021
Time for a new deal between neurology and psychoanalysis
Diego Centonze, Mario Stampanoni Bassi
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2020
Specific dietary interventions to tackle obesity should be a routine part of recommended MS care - Yes
Mario Stampanoni Bassi, Diego Centonze
Page
of 50
Search research articles
Search
Showing results (1-10 of 495) with videos related to
Sort By:
Page
of 50
European Neurology
|
October 4, 2014
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways
Diego Centonze
JAMA Neurology
|
February 10, 2015
Treatment decisions for patients with active multiple sclerosis
Olaf Stüve, Diego Centonze
Nature Metabolism
|
May 21, 2026
Irisin as a driver of neuroprotection in multiple sclerosis
Diego Centonze, Alessandra Musella
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 14, 2025
Diagnostic uncertainty in the era of biosimilar natalizumab-The case for harmonizing anti-JCV antibody testing
Tjalf Ziemssen, Diego Centonze
Sleep Science (Sao Paulo, Brazil)
|
December 28, 2019
Oral L-carnitine and pregnancy: real opportunity for narcoleptic women?
Andrea Romigi, Diego Centonze
Neurology and Therapy
|
October 31, 2021
Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
Carlo Avolio, Diego Centonze
Methods in Molecular Biology (Clifton, N.J.)
|
September 24, 2022
Electrophysiology of Endocannabinoid Signaling
Alessandra Musella, Diego Centonze
CNS Neuroscience & Therapeutics
|
December 6, 2014
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes
Vincenzo Di Marzo, Diego Centonze
Brain : a Journal of Neurology
|
July 20, 2021
Time for a new deal between neurology and psychoanalysis
Diego Centonze, Mario Stampanoni Bassi
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2020
Specific dietary interventions to tackle obesity should be a routine part of recommended MS care - Yes
Mario Stampanoni Bassi, Diego Centonze
Page
of 50